EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial

Maarten G Poirot, Henricus G Ruhe, Henk-Jan M M Mutsaerts, Ivan I Maximov, Inge R Groote, Atle Bjørnerud, Henk A Marquering, Liesbeth Reneman, Matthan W A Caan

American Journal of Psychiatry · 2024

DOI: 10.1176/appi.ajp.20230206 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Psychiatry, 2024. Verfasst von Maarten G Poirot und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine (Poirot, Ruhe, Marquering, Reneman) and Department of Biomedical Engineering and Physics (Poirot, Marque…. Hauptthemen laut MEDLINE: Sertraline, Major Depressive Disorder. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Response to antidepressant treatment in major depressive disorder varies substantially between individuals, which lengthens the process of finding effective treatment. The authors sought to determine whether a multimodal machine learning approach could predict early sertraline response in patients with major depressive disorder. They assessed the predictive contribution of MR neuroimaging and clinical assessments at baseline and after 1 week of treatment. METHODS: This was a preregistered secondary analysis of data from the Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care (EMBARC) study, a multisite double-blind, placebo-controlled randomized clinical trial that included 296 adult outpatients with unmedicated recurrent or chronic major depressive disorder. MR neuroimaging and clinical data were collected before and after 1 week of treatment. Performance in predicting response and remission, collected after 8 weeks, was quantified using balanced accuracy (bAcc) and area under the receiver operating characteristic curve (AUROC) scores. RESULTS: A total of 229 patients were included in the analyses (mean age, 38 years [SD=13]; 66% female). Internal cross-validation performance in predicting response to sertraline (bAcc=68% [SD=10], AUROC=0.73 [SD=0.03]) was significantly better than chance. External cross-validation on data from placebo nonresponders (bAcc=62%, AUROC=0.66) and placebo nonresponders who were switched to sertraline (bAcc=65%, AUROC=0.68) resulted in differences that suggest specificity for sertraline treatment compared with placebo treatment. Finally, multimodal models outperformed unimodal models. CONCLUSIONS: The study results confirm that early sertraline treatment response can be predicted; that the models are sertraline specific compared with placebo; that prediction benefits from integrating multimodal MRI data with clinical data; and that perfusion imaging contributes most to these predictions. Using this approach, a lean and effective protocol could individualize sertraline treatment planning to improve psychiatric care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SertralineMajor Depressive DisorderAdultHumansFemaleMaleDouble-Blind MethodAntidepressive AgentsMagnetic Resonance Imaging

Stichwörter der Autor:innen

AntidepressantsMachine LearningMajor Depressive DisorderSSRIs

Substanzen

SertralineAntidepressive Agents

Autor:innen und Institutionen

  • Department of Radiology and Nuclear Medicine (Poirot, Ruhe, Marquering, Reneman) and Department of Biomedical Engineering and Physics (Poirot, Marquering, Reneman, Caan), Amsterdam UMC Location AMC, University of Amster…

Zitieren

APA

Poirot, M. G., Ruhe, H. G., Mutsaerts, H. M. M., Maximov, I. I., Groote, I. R., Bjørnerud, A., Marquering, H. A., Reneman, L., & Caan, M. W. A. (2024). Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.20230206

Vancouver

Poirot MG, Ruhe HG, Mutsaerts HMM, Maximov II, Groote IR, Bjørnerud A, et al. Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial. American Journal of Psychiatry. 2024. doi:10.1176/appi.ajp.20230206

BibTeX
@article{Poirot2024,
  author = {Poirot, Maarten G and Ruhe, Henricus G and Mutsaerts, Henk-Jan M M and Maximov, Ivan I and Groote, Inge R and Bjørnerud, Atle and Marquering, Henk A and Reneman, Liesbeth and Caan, Matthan W A},
  title = {Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial},
  journal = {American Journal of Psychiatry},
  year = {2024},
  doi = {10.1176/appi.ajp.20230206}
}
Kostenlos starten →